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1. INTRODUCTION 
There have been many studies on percuraneous ab- 
sorption and cransdermal drug delivery systcma [I]. 
Some adhesive rrunxdermnl matrices have been uritized 
clinically [2]. The present authors have developed new 
penetration enhancers [3] and studied on Iiposornal 
assemblies [4-71 foe chemical sensing and drug dclivcry 
systems. In the present study, we tried to construct a 
liposomal system suitable for transdcrrnal drug delivery 
using N,N’ -long chain diacyl I,-cystine incorporated in- 
to the liposomal bitaycr with lecithin and cholesterol. 
2. MATERIALS AND METHODS 
Egg yolk lecithin (high grade) was purchased frown Asabi Chcmiral 
Industry Co. Dicetyl ahonphatc (RCP) and calcein wcrc nurchascd 
from N&nrai Tcs& inc. &A Wake Pure Chemical Co., &pective. 
ly. N,N’-Diacyl L-cystincs were prepared from L.cysrine and OCR 
tanoyl or lauroyl chloride by condensation reaction in NaOH-acetone 
at O°C overnight. Isolated precipitate was purified by crystallizatiori 
from ethanol and analyzed by means of IR and NMR spectrascopics, 
The cellophane membrane (10 ltrn thickness) was Visking cellophane 
tube. The kcratin membrane (180 pm thickness) was prepared from 
white leghorn hen feather, which was dissolved in 0.2 M thioglycolic 
acid (pH II in NaOH) at 50°C for 24 Ii, and the membrane was 
prepared by casting after dialytic purification of the solution. Other 
chemicals were all rcagellt grade. 
2.2. Prepararioa of model drug enmpped liposom 
A typical procedure was as follows; egg yolk lecithin (0.028 mmol), 
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rhal~rtcml (0,008 mmel), N,N”.dilrureyl L-cyxtinc (Cl&& 0.004 
mmol) wrr sprred on rhc boirram of R IQ8 ml raund-botramcd ltaxk 
from bl miscd aalwnr al CHCl~S%@H and wcrc dried under rcdw 
cd prcaurc. 0.4 mM calcein aolurlon (4 ml) af PBS buffer (pH 52) 
wdf udded 10 the flask, followed by vortex treatment for LS min and 
a slight sonic&n at 40 W for I tnin using R 13mnxen Yonificr, Cell 
Disruptor II% Extraneous calccin was removed by pcl permeation 
chrsmatoyruphy using Scphndex G-50 and the lipasamal fractions 
(clurian rnlume, 30-48 ml) in Fig. I, The size of the lipesames avereg. 
cd 178 nm. Lipoxomrx negatively stained with phosphotun&%tie acid 
were observed urinp an electron microscope (Fig. 2), The RI~OII~I of 
cnlscin cnfrnppcd in rhc lopoxonics was estimated at 25% from the 
difference between the fluorescence intensities of liposomc surpenm 
rionn with and without the addition of Triton X-100 [8], 
2.3. Met~rQratw pcrnrecrrion procedrtre 
Menrbranc was clanlped between two half cells (Fig. 3), which wcrc 
placed on a platform in a wauzr bath maintained al 37,OztzO9C. 
Liposomal suspension (30 ml) was placed in the donor-half cell and 30 
ml of PDS buffer (pH 7.2) in the opposire cell. The stirrer motors were 
started, and the stirrer propellers were conrrolled to 120 pm. Samples 
(4 ml) were removed from the rccipient.half cell at suitable time inter- 
vals and assayed spcctrophotornetrically. Permeation experiments 
were continued for 300 min or more. 
2+4 I Instnctnenfs 
A transmitting electron microscope (Hitachi HU-I2A) was used to 
observe the liposotnes, Liposomal sizes were measured using a 
Coultcr N-4 Submicron Particle Analyzer. The amount of calcein was 
determined fluorometrically using a Shimadzu RF-540 spec- 
trofluoromerer at 520 mn at the excitation wavelength of 480 nni. The 
amount of paminobenzoic acid (PABA) was determined at 277 nm 
using a Hitachi spectrophotomcter Model 101. 
3. RESULTS AND DISCUSSION 
3.1. Trcmfer of hposormily entrapped drugs across 
keratin and cellophane membranes 
Keratin is known to form the stratum corneum of 
human skin and is a disuIfide bonding-rich protein 
composed of amino acids with sequential networks 
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Fig. 2. Electron micrograph of negatively stained liposomes consisting of egg lecithin/cholesterol/Clz-SS 
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trapped calcein across the keratin membrane were car- 
ried out until 300 min (Fig, 3), The effect of the con- 
sriturionsof the lipooomes on ealccin teansfer in obvious 
in Fig. 4. Namely, the g~cater the content OF CtpSS in 
C~C liposomal bilayers, the grcatcc the permeation of 
liposomally entrapped calcein, It may be also noted chat 
the liposomal system without CIZ-SS (Fig. 4) also 
enhances calccin release in agreement with the rcsulc of 
Katoh [lo]. In facr, C12-SS (30 mol%) or DCP (10 
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Fig. 5. Transfer of PABA across the cellophane membrane from 
PABA-consisting liposomfs (donor cell: liposomal suspension in PBS 
(pH 5.2), 30 ml; recipient cell: PBS (pH 7.2), 30 ml). 
Conrtilurbon crl liposomw (moior rolio) 
Fig. 6. Drrcrp~ien crl adwbed rrlecin from Ihe kerntin and 
ccllophanr: mcmbrtmrx immrrred 4n PBS (pPI “IA) afw finishins the 
axperimrnrx or Pips. J nnd 5. 
mol%) containing ligosome cause 14. or It-FoId in- 
crease in enlcein pcrmcation over the 0,4 mM ealcein 
solution in Fig. 4. Incidcntolly, fhLt amount of 
liposomally entrapped calcein in the donor ccl1 was 
calculated to be ea. 3 qnol and reduced to 0.7 ltmol at 
the maximum after 300 min in Fig. 4. A similar result 
was obtained spectrophotomecrically for PARA 
permeation when 0.3 n-M PABA solution was introduc- 
cd into the donor cell instead of 0.4 mM calcein, Free 
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Fig. 7. Leakage of calcein in the liposomes consisting of 
Iecithin/cholesterol/C~~-SS (70:20:10) prepared at pH 7.2. 
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tigosomally eotrqaped model dsugo tkrouyh kerarin nnd 
eellophanc WJ found in section 3.1. The amount of cal- 
eein adsorbed onto the keratin and celtophnne was 
determined fluorometrically for the membranes used in 
the experiments of Figs. 4 and 5. The membranes were 
washed twice with water. The test yieecs were then im- 
mersed in 4 ml PBS (pW 7.2) of fluoromctric cells and 
their fluorescent intensities were measured until 120 
min after removing the pieces outside. The results are 
shown in Fig. 6. The value at 120 min seems to be the 
equilibrium value, Keratin holds calcein and increases 
the amount with increases in C12-SS in the liposomal 
bilayer. Kcratin is also able to hold calccin even with 
liposomes without C12-SS. Cellophane holds only a 
small amount of calccin, Therefore, it was concluded 
that CI~-SS and the basic liposomal constituents of 
lecithin and cholesterol have an affinity for kcratin. 
C12-SS has an especially large affinity, This seems to be 
due to the mediating (or accompanying) action of 
C12-SS for calcein as an amphiphilc. This is meaningful 
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POP t~~nstl~rm~l ~~~t~~.rii~rn, bccaurc stratum eglrnfum 
~u~s~stin$ OP ksratin is known to bo the lntrrfering bar- 
rier for ~~r~~~t~n~o~~ abrarption aE drugs. The groper 
nff%lty fsf CC&S far kerarin may be rrttributed to their 
in~~r~~n~fr~t~~n em rhc brisk -cllf the cii~ulf’ide=rich 
rtrzlefurc 01 kcratin. tshii (I l] diseusxcd the interaction 
beW%en liparomcs and the skin in citing (91, We took 
thicr! plgrltian that lipasomcs cnhnnee drug transfer inside 
the &in, but that liperomer do not penetrate the skin 
itself. Ic i?i ttlaa important to, point out the pH-sensitive 
prapcrty erfIV,@J’-dincyl L-chorine. Namely, C&S cnn 
Q&I strony nwf’a’ncc? nctiviry by changing to earboxylate 
ions in contact with the alkaline en.vironmcnt (pH 7,2) 
in ~lr@ reciplcnr ecll. It is obvious from Fig. 7 thrrt Ctl-SS 
conmining liposomes txnnot hold eniccin inside at pH 
7.2, Thus, N,N’-dincyl 6.cystinc plays an impartant 
rote in the acceleration of cnlccin transfer thrau& 
kerntin, 
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